Worldwide study of the taste of bitter medicines and their modifiers
Chemical Senses · 2025
DOI: 10.1093/chemse/bjaf003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Senses, 2025. Verfasst von Ha Nguyen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Monell Chemical Senses Center, Philadelphia, PA, United States. Hauptthemen laut MEDLINE: Taste. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Gates Foundation, NINR NIH HHS, Monell Chemical Senses Center's Carol M. Christensen Postdoctoral Fellowship in Human Chemosensory Science Fund.
Abstract (Originalsprache)
The bitter taste of medicines hinders patient compliance, but not everyone experiences these difficulties because people worldwide differ in their bitterness perception. To better understand how people from diverse ancestries perceive medicines and taste modifiers, 338 adults, European and recent US and Canadian immigrants from Asia, South Asia, and Africa, rated the bitterness intensity of taste solutions on a 100-point generalized visual analog scale and provided a saliva sample for genotyping. The taste solutions were 5 medicines, tenofovir alafenamide (TAF), moxifloxacin, praziquantel, amodiaquine, and propylthiouracil (PROP), and 4 other solutions, TAF mixed with sucralose (sweet, reduces bitterness) or 6-methylflavone (tasteless, reduces bitterness), sucralose alone, and sodium chloride alone. Bitterness ratings differed by ancestry for 2 of the 5 drugs (amodiaquine and PROP) and for TAF mixed with sucralose. Genetic analysis showed that people with variants in 1 bitter receptor variant gene (TAS2R38) reported PROP was more bitter than did those with a different variant (P = 7.6e-19) and that people with either an RIMS2 or a THSD4 genotype found sucralose more bitter than did others (P = 2.6e-8, P = 7.9e-11, respectively). Our findings may help guide the formulation of bad-tasting medicines to meet the needs of those most sensitive to them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Monell Chemical Senses Center, Philadelphia, PA, United States.
- Clinton Health Access Initiative, Boston, MA, United States.
- National Institute of Alcohol Abuse and Alcoholism and National Institute of Nursing Research, Bethesda, MD, United States.
- Countess of Chester Hospital, Chester, United Kingdom.
ORCID-Profile: Ha Nguyen, Cailu Lin, Katherine Bell, Amy Huang, Mackenzie Hannum, Vicente Ramirez, Nancy E Rawson, Riley Herriman, Paule Joseph, Oghogho Braimah, Danielle R Reed
Förderung
- Gates Foundation
- NINR NIH HHS
- Monell Chemical Senses Center's Carol M. Christensen Postdoctoral Fellowship in Human Chemosensory Science Fund
- Office of Workforce Diversity
- Rockefeller University Heilbrunn Nurse Scholar Award
- NIH HHS
- NIDCD NIH HHS
- Monell Chemical Senses Center Institutional Funds
Zitieren
APA
Nguyen, H., Lin, C., Bell, K., Huang, A., Hannum, M., Ramirez, V., Christensen, C., Rawson, N. E., Colquitt, L., Domanico, P., Sasimovich, I., Herriman, R., Joseph, P., Braimah, O., & Reed, D. R. (2025). Worldwide study of the taste of bitter medicines and their modifiers. Chemical Senses. https://doi.org/10.1093/chemse/bjaf003
Vancouver
Nguyen H, Lin C, Bell K, Huang A, Hannum M, Ramirez V, et al. Worldwide study of the taste of bitter medicines and their modifiers. Chemical Senses. 2025. doi:10.1093/chemse/bjaf003
BibTeX
@article{Nguyen2025,
author = {Nguyen, Ha and Lin, Cailu and Bell, Katherine and Huang, Amy and Hannum, Mackenzie and Ramirez, Vicente and Christensen, Carol and Rawson, Nancy E and Colquitt, Lauren and Domanico, Paul and Sasimovich, Ivona and Herriman, Riley and Joseph, Paule and Braimah, Oghogho and Reed, Danielle R},
title = {Worldwide study of the taste of bitter medicines and their modifiers},
journal = {Chemical Senses},
year = {2025},
doi = {10.1093/chemse/bjaf003}
}
EUVIMED